A new cure has been discovered to help treat erectile dysfunction; however, the men might wince at the thought of this idea. A study from Israel has announced promising preliminary consequences from using low-intensity shock wave therapy to help treat vasculogenic erectile dysfunction (ED).

Indeed, 15 out of the 20 patients who suffered from mild or moderate ED who have been treated so far had a major advance with their erectile function, and in most cases were able to discontinue treatment with phosphodiesterase inhibitors.

Yoram Vardi, M.D., chief of the neuro-urology unit at the Rambam Medical Center in Haifa, presented the current findings at the yearly assembly of the European Society for Sexual Medicine. He explained that the low-energy shock wave therapy is being more and more used to help induce renewal of small coronary vessels in patients that have angina and who are not appropriate for angioplasty or coronary surgery.
For the duration of each of the treatment sessions, the low-energy shock wave therapy was applied on the penile shaft and curs for just about three minutes in each of the five anatomical sites. The shock waves are one-tenth the level of intensity as the shock waves that are used to pulverize kidney stones. The men underwent a three-week course of two weekly treatment sessions and then a second indistinguishable round of therapy that started three weeks later. The erectile dysfunction was assessed at the time of conscription and then four weeks after the end of their treatment.

Vardi mentioned that the protocol used to improve vasculogenesis of the ischemic heart is the same one we used to treat ED. The consequences showed that the IIEF-ED score enhanced by more than 5 points in 15 patients, which is around 75 percent of the group. Seven out of the 20 patients, or about 35 percent, showed an improvement of more than 10 points on the scale. The six-month follow up data showed that 12 out of the 15 patients who enhanced appreciably with the shock treatment said that they no longer needed to use the PDE-5 inhibitors to help treat their situation.The scores on several other validated ED questionnaires such as Self-Esteem and Relationship Questionnaire, Quality of Erection Questionnaire, and the Erectile Dysfunction Inventory of Treatment Satisfaction also showed important development. The research analysis also showed a major enhancement in the baseline and maximal flow values on a penile endothelial function test.